1 / 24

Barbiturates

Barbiturates. 4 th Year Pharmacy 2015-2016. Introduction. The barbiturates were used extensively as sedative–hypnotic drugs. Except for a few specialized uses, they have been replaced largely by the much safer benzodiazepine. Barbiturates act throughout the CNS. Ⅱ. BARBITURATES.

alverta
Download Presentation

Barbiturates

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Barbiturates 4th Year Pharmacy 2015-2016

  2. Introduction • The barbiturates were used extensively as sedative–hypnotic drugs. Except for a few specialized uses, they have been replaced largely by the much safer benzodiazepine. • Barbiturates act throughout the CNS

  3. Ⅱ.BARBITURATES Classification • Ultra-short-acting barbiturates: act within seconds, and their duration of action is 30min. Therapeutic use of Thiopental: anesthesia • Short-actingbarbiturates: have a duration of action of about 2h. The principal use of Secobarbital : sleep-inducing hypnotics.

  4. (3)Intermediate-acting barbiturates: have and effect lasting 3-5h. The principal use of Amobarbital is as hypnotics. • (4)Long-acting barbiturates: have a duration of action greater than 6h. Such as Barbital and Phenobarbital. Therapeutic uses: hypnotics and sedative, and antiepileptic agents at low doses

  5. BARBITURATES Barbiturates depress the CNS at all level in a dose-dependent fashion. Now it mainly used in anaesthesia and treatment of epilepsy; use as sedative-hypnotic agents is no longer recommended.

  6. BARBITURATES Reasons: (1) have a narrow therapeutic-to-toxic dosage range. (2) suppress REM sleep. (3) Tolerance develops relatively quickly. (4) have a high potential for physical dependence and abuse. (5) potent inducers of hepatic drug-metabolizing enzymes.

  7. MECHANISM OF ACTION (1) Barbiturates share with benzodiazepines the ability to enhance the action of GABA, but they bind a different site on the GABA-receptor/chloride channel, and their action seems to prolong the duration of the opening of GABA-activated chloride channels.

  8. MECHANISM OF ACTION (2) At high doses, barbiturates can inhibit the release of the Ca2+-dependent neurotransmitter.

  9. Synthesis of Barbiturates • Diethyl malonate + Urea = B.A.

  10. Barbiturates Barbiturates are 5,5 disubstituted barbituric acid

  11. Structure activity relationship of BA • General SAR • 1- 1,3 disubstituted barbiturate is inactive • 2-1,3 disubstituted thio barbiturate is inactive • 3- 5-mono substituted BA is inactive • 4- 5-mono substituted thio BA is inactive • 5- 1,3,5 trisustituted BA is inactive • 6-1,3,5 trisubstituted thio BA is inactive. • 5,5,disubstituted BA is active • 5,5 disubstituted thio BA is active.

  12. Position 2 O, S • Increase lipophlic Thio barbituate increase onset ( Thiopental) • Position 5 • 1. Both hydrogen atoms at position 5 should be substituted (pka ≈ 7.6). The unsubstituted or monosubstituted are very acidic (pka ≈ 4) so the compounds are largely ionized at physiological pHs, with little lipid soluble compound available to cross the BBB

  13. . 2. Polar functions at C5. 3. Methylene and benzylidene moiety. 4. Substituents with total number of carbon atoms greater than 9

  14. Metabolism of BA • 1- Ring Hydroxylation • 2- OMEG &OMEA -1 Oxidation • 3- Replacement O by S • 4- Ring cleavage • H.W: Draw equation for the metabolism?

  15. Pharmacokinetics • High lipid solubility allows rapid transport across the blood-brain barrier and results in a short onset. • Removal from the brain occurs via redistribution to the other tissues results in short duration of action. • Barbiturates and their metabolites the excretion via the renal route. Alkalinization of the urine expedites the excretion of barbiturates. Treatment of acute overdosage: Sodium bicarbonate.

  16. Therapeutic uses • Sedative-hypnotic agents • Be used in the emergency treatment of convulsions as in status epilepticus. • Anesthetic (or be given before anesthetic) • Combination with antipyretic-analgesic • Treatment of hyperbilirubinemia and kernicterus in the neonate.

  17. Adverse effects • After effect: hangover---dizzy, drowsiness, amnesia, impaired judgment, disorientation. • Tolerance: decreased responsiveness to a drug following repeated exposure because of down-regulation of receptors and induction of hepatic drug-metabolising enzymes.

  18. Adverse effects • Dependence: including psychological and physiologic dependence. Withdrawal symptoms: excitation, insomnia, tremor, anxiety, hallucinations and sometimes convulsions. • Depressant effect on respiration: can cross the placental barrier during pregnancy and secrete to breast milk. • Others: Skin eruptions and porphyria

  19. Treatment of acute overdosage • An overdose can result in coma, diminished reflexes, severe respiratory depression, hypotension leading to cardiovascular collapse, and renal failure. • Treatment (A.B.C): (1) supporting respiration and circulation. (2) alkalinizing the urine and promoting diuresis. (3) Hemodialysis or peritoneal dialysis.

  20. Ⅲ.Nonbarbiturate sedative-hypnotics • AMIDES AND IMIDES • Alcohols • Carbamate • Aldehyde

  21. Ethchlorvynol, USP. • 1-chloro-3-ethyl-1-penten-4-yn-3-ol (Placidyl), • is a mild sedative–hypnotic with • a quick onset and short duration of action (t1/2 5.6 hours). • Because of its highly lipophilic character, it is extensively metabolized to its secondary alcohol (90%) prior to itsexcretion. It reportedly induces microsomal hepatic enzymes.

  22. Amides & Imides • Glutethimide, 2-ethyl-2-phenylglutarimide • (Doriden), is one of the most active nonbarbiturate hypnotics that is structurally similar to the barbiturates,especially phenobarbital. Because of glutethimide’s low aqueous solubility, • Glutethimide is used as a racemic mixture with the ( +) enantiomer being primarily metabolized on the glutarimide ring and the ( - ) enantiomer on the phenyl ring.

  23. Meprobamate, USP. • 2-methyl-2-propyltrimethylene dicarbamate, 2-methyl-2-propyl-1,3- propanediol dicarbamate (Equanil) • Meprobamate is also a centrally acting skeletal muscle relaxant. The agents in this group find use in several conditions, such as strains and sprains that may produce acute • muscle spasm

  24. Aldehyde Chloral hydrate is 2,2,2 trichloroacetaldehyde. (1) relatively safe hypnotic, inducing sleep in a half hour and lasting about 6h. (2) used mainly in children and the elder, and the patients when failed to other drug.

More Related